公司资料
LeMaitre Vascular 股价、新闻与催化剂
- 股票代码:
- LMAT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
80.19 USD (-2.91%)
收盘价
最后更新: 2026年10月1日
2.09B USD
市值
股价为何变动
截至 2026年10月1日，LMAT 下跌 2.91%，收于 $80.19。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Vascular Device Company
LeMaitre Vascular develops devices, implants, and services used by vascular surgeons to treat peripheral vascular disease. Its portfolio is focused on open surgical and endovascular procedures outside the heart.
Grafts and Biological Implants
The company offers synthetic vascular grafts, Artegraft biological grafts, vascular patches, and related implants used to repair or replace diseased vessels. These products generate procedure-linked demand and are supported by specialized surgeon relationships.
Catheters and Surgical Tools
LeMaitre supplies embolectomy catheters, occlusion catheters, carotid shunts, valvulotomes, and other devices used during vascular reconstruction. The portfolio addresses multiple steps within common vascular procedures.
Direct Commercial Model
The company primarily sells through a direct sales force in major markets, supported by distributors elsewhere. Acquisitions and internal product development are used to expand the portfolio offered to the same vascular-surgery customer base.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。